Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BPYMAC

Financiado

Cerrado

Bipyridines as Mediating Artificial Cofactors to replace NAD(P)H

In the quest for a sustainable and eco-friendly future, enzymatic catalysis has emerged as a pivotal platform, steering chemical synthesis towards environmentally benign pathways. The use of natural cofactors such as NADH (nicotin... ver más

30/06/2026

CSIC

165K€

Presupuesto del proyecto: 165K€

Líder del proyecto

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 2-3 | 552M€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-04-04

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 1 año

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

CSIC

165.31K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CTQ2014-55015-P DESARROLLO DE NUEVAS TRANSFORMACIONES BIOCATALITICAS SELECTI... 120K€ Cerrado

PID2019-111300GA-I00 CARACTERIZACION MULTIESCALAR DE INTERMEDIOS REACTIVOS PARA E... 73K€ Cerrado

PhotoBioCat Light driven sustainable biocatalysis training network 3M€ Cerrado

SusECAS - DemoPlant Metaraminol Demonstration Plant as Commercialisation Bluepri... 150K€ Cerrado

ChemoEnz Chemo Enzymatic Manufacturing Routes to High Value compound... 234K€ Cerrado

ReCNNSTRCT Reconstructing enzymes for novel nitrogen-nitrogen bond form... 2M€ Cerrado

Duración del proyecto: 26 meses Fecha Inicio: 2024-04-04
Fecha Fin: 2026-06-30

Líder del proyecto

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 2-3 | 552M€

Presupuesto del proyecto 165K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto In the quest for a sustainable and eco-friendly future, enzymatic catalysis has emerged as a pivotal platform, steering chemical synthesis towards environmentally benign pathways. The use of natural cofactors such as NADH (nicotinamide adenine dinucleotide, reduced) and NADPH (nicotinamide adenine dinucleotide phosphate, reduced) has been instrumental in these processes, providing essential reducing equivalents for numerous enzymatic transformations. In the production of valuable chemicals and pharmaceuticals via biocatalysis, NAD(P)H is utilized by various enzymes.NAD(P)H-dependent processes play a key role in pharmaceutical industry and the environment (reducing CO2 emissions), in the production of valuable fuels and chiral active pharmaceutical ingredients (APIs).While NAD(P)H is effective as a cofactor, it presents several issues that limit its practicality and sustainability – mainly due to high cost of cofactor, high process costs due to lack of recyclability and complex downstream processing. The central idea of BPYMAC is to leverage the advantages of bipyridines as ideal mediating artificial cofactors (MACs) to replace NAD(P)H due to their synthetic versatility, recyclability, tunability and stability. Synthetic strategies enable their conversion to redox polymer enabling their application as polymer films on electrodes, allowing their use in reactors with facile product separation. This will be the end goal of BPYMAC, meeting significant gaps in the state of the art. BPYMAC's research outcomes will help revolutionise bioelectrocatalyis by targeting synthesis of valuable products from CO2 reduction and production of chiral APIs in a reactor consisting of polymeric MAC and enzyme, optimised to produce products in high yield and with high stereoselectivity. These reactions will provide proof-of-concept for the potential of BPYMAC's tailored MACs as NAD(P)H replacements for reactions of interest for industry, society and the scientific community.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores